CYTHW
Closed
Cyclo Therapeutics Inc
0.032
0.000 (0.00%)
Last Update: 26 Mar 2025 16:30:00
Yesterday: 0.032
Day's Range: 0.032 - 0.032
Send
sign up or login to leave a comment!
When Written:
0.28
Cyclo Therapeutics Inc is a biotechnology company that is focused on developing therapies for patients suffering from serious and life-threatening diseases. The company's lead product candidate, Trappsol Cyclo, is a proprietary formulation of hydroxypropyl-beta-cyclodextrin (HPβCD) that is being developed for the treatment of Niemann-Pick Disease Type C (NPC), a rare and fatal genetic disorder.
Trappsol Cyclo has been granted Fast Track designation by the US Food and Drug Administration (FDA) and orphan drug designation by both the FDA and the European Medicines Agency (EMA). The company is also developing a pipeline of other HPβCD-based therapeutics for the treatment of other rare diseases, including Alzheimer's disease and ALS.
Cyclo Therapeutics Inc was founded in 2013 and is headquartered in Gainesville, Florida. The company is publicly traded on the NASDAQ under the ticker symbol CYTH.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Trappsol Cyclo has been granted Fast Track designation by the US Food and Drug Administration (FDA) and orphan drug designation by both the FDA and the European Medicines Agency (EMA). The company is also developing a pipeline of other HPβCD-based therapeutics for the treatment of other rare diseases, including Alzheimer's disease and ALS.
Cyclo Therapeutics Inc was founded in 2013 and is headquartered in Gainesville, Florida. The company is publicly traded on the NASDAQ under the ticker symbol CYTH.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!